BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34362487)

  • 1. [Clinical and Pathological Characteristics of Aggressive Natural Killer Cell Leukemia Patients].
    Wang LP; Yu YP; Mei JG; Song P; An ZM; Zhou XG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1093-1100. PubMed ID: 34362487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinicopathologic features of aggressive natural killer cell leukemia].
    Liu EB; Chen HS; Zhang PH; Li ZQ; Sun Q; Yang QY; Fang LH; Sun FJ
    Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):810-4. PubMed ID: 22336205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EBV-negative Aggressive NK-cell Leukemia/Lymphoma: Clinical, Pathologic, and Genetic Features.
    Nicolae A; Ganapathi KA; Pham TH; Xi L; Torres-Cabala CA; Nanaji NM; Zha HD; Fan Z; Irwin S; Pittaluga S; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2017 Jan; 41(1):67-74. PubMed ID: 27631517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent CD7 antigen loss in aggressive natural killer-cell leukemia: a useful diagnostic marker.
    Yoo EH; Kim HJ; Lee ST; Kim WS; Kim SH
    Korean J Lab Med; 2009 Dec; 29(6):491-6. PubMed ID: 20046078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult aggressive natural killer cell leukemia.
    Zhang H; Meng Q; Yin W; Xu L; Lie L
    Am J Med Sci; 2013 Jul; 346(1):56-63. PubMed ID: 23241562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Killer Cell Activity Test Helps to Suspect Aggressive Natural Killer Cell Leukemia - Diagnostic Challenge.
    You E; Park CJ; Lee MY; Cho YU; Jang S; Lee JH; Lee JH; Lee KH
    Int J Med Sci; 2023; 20(2):206-210. PubMed ID: 36794163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus (EBV)-induced CD30+ natural killer cell-type malignancy resembling malignant histiocytosis: malignant transformation in chronic active EBV infection associating hypogammaglobulinemia.
    Tsutsumi Y; Tang X; Yamada T
    Pathol Int; 1997 Jun; 47(6):384-92. PubMed ID: 9211526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic and Immunophenotypic Landscape of Aggressive NK-Cell Leukemia.
    El Hussein S; Patel KP; Fang H; Thakral B; Loghavi S; Kanagal-Shamanna R; Konoplev S; Jabbour EJ; Medeiros LJ; Khoury JD
    Am J Surg Pathol; 2020 Sep; 44(9):1235-1243. PubMed ID: 32590457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells.
    Suzuki R; Suzumiya J; Nakamura S; Aoki S; Notoya A; Ozaki S; Gondo H; Hino N; Mori H; Sugimori H; Kawa K; Oshimi K;
    Leukemia; 2004 Apr; 18(4):763-70. PubMed ID: 14961041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.
    Chan JK; Sin VC; Wong KF; Ng CS; Tsang WY; Chan CH; Cheung MM; Lau WH
    Blood; 1997 Jun; 89(12):4501-13. PubMed ID: 9192774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow Cytometric Immunophenotyping Is Sensitive for the Early Diagnosis of De Novo Aggressive Natural Killer Cell Leukemia (ANKL): A Multicenter Retrospective Analysis.
    Li Y; Wei J; Mao X; Gao Q; Liu L; Cheng P; Liu L; Zhang X; Zhang K; Wang J; Zhu L; Zhou J; Zhang Y; Meng L; Sun H; Li D; Huang M; Huang W; Deng J; Zhang D
    PLoS One; 2016; 11(8):e0158827. PubMed ID: 27483437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monomorphic agranular natural killer cell lymphoma/leukemia with no Epstein-Barr virus association.
    Matano S; Nakamura S; Nakamura S; Annen Y; Hattori N; Kobayashi K; Kyoda K; Sugimoto T
    Acta Haematol; 1999; 101(4):206-8. PubMed ID: 10436303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achievement of disease control with donor-derived EB virus-specific cytotoxic T cells after allogeneic peripheral blood stem cell transplantation for aggressive NK-cell leukemia.
    Haji S; Shiratsuchi M; Matsushima T; Takamatsu A; Tsuda M; Tsukamoto Y; Tanaka E; Ohno H; Fujioka E; Ishikawa Y; Imadome KI; Ogawa Y
    Int J Hematol; 2017 Apr; 105(4):540-544. PubMed ID: 27830541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunophenotypic Dissection of Normal Peripheral Blood NK Associated (NKa) Subpopulations by Flow Cytometry: Morphological Features and Relationships Between Membrane NKa (CD11b, CD 16, CD56 and CD57) arid T-cell (CD2, CD3, TCR, CD5, CD7, CD8 and CD38) Associated Determinant Expression.
    Richards SJ; Scott CS
    Leuk Lymphoma; 1990; 2(1-2):111-26. PubMed ID: 27456578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
    Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
    Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoplasmic Expression of CD3ε Heterodimers by Flow Cytometry Rapidly Distinguishes Between Mature T-Cell and Natural Killer-Cell Neoplasms.
    Shi M; Nguyen P; Timm MM; Otteson GE; Horna P; Olteanu H; Jevremovic D
    Am J Clin Pathol; 2020 Oct; 154(5):683-691. PubMed ID: 32589191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Favorable outcome in a child with EBV-negative aggressive NK cell leukemia.
    Park JA; Jun KR; Nam SH; Ghim TT
    Int J Hematol; 2013 May; 97(5):673-6. PubMed ID: 23550023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection.
    Tsuchiyama J; Yoshino T; Mori M; Kondoh E; Oka T; Akagi T; Hiraki A; Nakayama H; Shibuya A; Ma Y; Kawabata T; Okada S; Harada M
    Blood; 1998 Aug; 92(4):1374-83. PubMed ID: 9694726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggressive natural killer cell leukemia or extranodal NK/T cell lymphoma? a case with nasal involvement.
    Jin X; Xu Y; Zhang J; Li G; Huang D; Yang Y; He H
    Diagn Pathol; 2017 Jun; 12(1):46. PubMed ID: 28623913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin.
    Cooke CB; Krenacs L; Stetler-Stevenson M; Greiner TC; Raffeld M; Kingma DW; Abruzzo L; Frantz C; Kaviani M; Jaffe ES
    Blood; 1996 Dec; 88(11):4265-74. PubMed ID: 8943863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.